Interleukin-6 serum level assessment using a new qualitative point-of-care test in sepsis: A comparison with ELISA measurements

Clinical Biochemistry

Volumn 41, Issue 10-11, 2008, Pages 893-898

  Schefold, Joerg C ^a   Hasper, Dietrich ^a   von Haehling, Stephan ^a   Meisel, Christian ^a   Reinke, Petra ^a   Schlosser, Hans Georg ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Immune system; Inflammation; Septic shock; Severe sepsis; Tissue injury

Indexed keywords

INTERLEUKIN 6;

ADULT; APACHE; AREA UNDER THE CURVE; ARTICLE; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CORRELATION ANALYSIS; DENSITOMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; POINT OF CARE TESTING; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; SEPSIS; STATISTICAL SIGNIFICANCE;

ADULT; APACHE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTENSIVE CARE UNITS; INTERLEUKIN-6; MALE; MIDDLE AGED; POINT-OF-CARE SYSTEMS; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SEPSIS; SHOCK, SEPTIC;

EID: 44949101156     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2008.03.008     Document Type: Article

References (34)

1. Annane D., Bellissant E., and Cavaillon J.M. Septic shock. Lancet 365 9453 (2005) 63-78
2. Hotchkiss R.S., and Karl I.E. The pathophysiology and treatment of sepsis. N Engl J Med 348 2 (2003) 138-150
3. Angus D.C., Linde-Zwirble W.T., Lidicker J., Clermont G., Carcillo J., and Pinsky M.R. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29 7 (2001) 1303-1310
4. Annane D., Aegerter P., Jars-Guincestre M.C., and Guidet B. Current epidemiology of septic shock: the CUB-Rea Network. Am J Respir Crit Care Med 168 2 (2003) 165-172
5. Cohen J. The immunopathogenesis of sepsis. Nature 420 6917 (2002) 885-891
6. Cavaillon J.M., Adib-Conquy M., Fitting C., Adrie C., and Payen D. Cytokine cascade in sepsis. Scand J Infect Dis 35 9 (2003) 535-544
7. Heinrich P.C., Behrmann I., Haan S., Hermanns H.M., Muller-Newen G., and Schaper F. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J 374 Pt 1 (2003) 1-20
8. Van Snick J. Interleukin-6: an overview. Annu Rev Immunol 8 (1990) 253-278
9. Oberholzer A., Oberholzer C., and Moldawer L.L. Cytokine signaling-regulation of the immune response in normal and critically ill states. Crit Care Med 28 4 Suppl (2000) N3-N12
10. Kuster H., Weiss M., Willeitner A.E., et al. Interleukin-1 receptor antagonist and interleukin-6 for early diagnosis of neonatal sepsis 2 days before clinical manifestation. Lancet 352 9136 (1998) 1271-1277
11. Volante E., Moretti S., Pisani F., and Bevilacqua G. Early diagnosis of bacterial infection in the neonate. J Matern Fetal Neonatal Med 16 Suppl 2 (2004) 13-16
12. Waage A., Brandtzaeg P., Halstensen A., Kierulf P., and Espevik T. The complex pattern of cytokines in serum from patients with meningococcal septic shock: association between interleukin 6, interleukin 1, and fatal outcome. J Exp Med 169 (1989) 333-338
13. Dellinger R.P., Carlet J.M., Masur H., et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 32 3 (2004) 858-873
14. Rivers E., Nguyen B., Havstad S., et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345 19 (2001) 1368-1377
15. Bochud P.Y., Bonten M., Marchetti O., and Calandra T. Antimicrobial therapy for patients with severe sepsis and septic shock: an evidence-based review. Crit Care Med 32 11 Suppl (2004) S495-S512
16. Rhodes A., and Bennett E.D. Early goal-directed therapy: an evidence-based review. Crit Care Med 32 11 Suppl (2004) S448-S450
17. van den Berghe G., Wouters P., Weekers F., et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 345 19 (2001) 1359-1367
18. Vincent J.L., Abraham E., Annane D., Bernard G., Rivers E., and Van den Berghe G. Reducing mortality in sepsis: new directions. Crit Care 6 Suppl 3 (2002) S1-S18
19. Damas P., Ledoux D., Nys M., et al. Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Ann Surg 215 4 (1992) 356-362
20. Gomez R., Romero R., Ghezzi F., Yoon B.H., Mazor M., and Berry S.M. The fetal inflammatory response syndrome. Am J Obstet Gynecol 179 1 (1998) 194-202
21. Gonzalez B.E., Mercado C.K., Johnson L., Brodsky N.L., and Bhandari V. Early markers of late-onset sepsis in premature neonates: clinical, hematological and cytokine profile. J Perinat Med 31 1 (2003) 60-68
22. Harbarth S., Holeckova K., Froidevaux C., et al. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 164 3 (2001) 396-402
23. Krueger M., Nauck M.S., Sang S., Hentschel R., Wieland H., and Berner R. Cord blood levels of interleukin-6 and interleukin-8 for the immediate diagnosis of early-onset infection in premature infants. Biol Neonate 80 2 (2001) 118-123
24. Oberholzer A., Souza S.M., Tschoeke S.K., et al. Plasma cytokine measurements augment prognostic scores as indicators of outcome in patients with severe sepsis. Shock 23 6 (2005) 488-493
25. Levy M.M., Fink M.P., Marshall J.C., et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 31 4 (2003) 1250-1256
26. Lin L.I.K.A. A concordance correlation coefficient to evaluate reproducibility. Biometrics 45 (1989) 255-268
27. Pettila V., Hynninen M., Takkunen O., Kuusela P., and Valtonen M. Predictive value of procalcitonin and interleukin 6 in critically ill patients with suspected sepsis. Intensive Care Med 28 (2002) 1220-1225
28. Oberholzer A., Souza S.M., Tschoeke S.K., et al. Plasma cytokine measurements augment prognostic scores as indicators of outcome in patients with severe sepsis. Shock 23 (2005) 488-493
29. Pathan N., Hemingway C.A., Alizadeh A.A., et al. Role of interleukin 6 in myocardial dysfunction of meningococcal septic shock. Lancet 363 (2004) 203-209
30. Schefold J.C., von Haehling S., Corsepius M., et al. A novel selective extracorporeal intervention in sepsis: immunoadsorption of endotoxin, interleukin 6, and complement-activating product 5a. Shock 28 4 (2007) 418-425
31. Rose-John S., Waetzig G.H., Scheller J., Grötzinger J., and Seegert D. The IL-6/sIL-6R complex as a novel target for therapeutic approaches. Expert Opin Ther Targets 11 (2007) 613-624
32. Schefold J.C., Hasper D., Storm C., Corsepius M., Pschowski R., and Reinke P. The extracorporeal treatment of septic patients: is there an extrarenal indication?. Intensivmedizin und Notfallmedizin 44 (2007) 57-63
33. Görbe E., Jeager J., Nagy B., et al. Assessment of serum interleukin-6 with a rapid test. The diagnosis of neonatal sepsis can be established or ruled out. Orv Hetil 148 (2007) 1609-1611
34. Schlosser H.G., Volk H.D., Splettstösser G., Brock M., and Woiciechowsky C. A new qualitative interleukin-6 bedside test can predict pneumonia in patients with severe head injury. J Neurosurg Anesthesiol 19 (2007) 5-9